R906289 Monosodium

Overview

R906289 Monosodium is a small molecule IRAK1 and IRAK4 inhibitor currently being studied for use in myelodysplastic syndrome (MDS).

SparkCures ID 475
Generic Name R906289 Monosodium
Treatment Classifications
  • IRAK 1 Inhibitor
  • IRAK 4 Inhibitor

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.